Skip to main content
SpringerLink
Log in

Endometriosis and Pelvic Pain

  • Chapter
Chronic Pelvic Pain

Abstract

Endometriosis is a common disorder confronting any physician that cares for reproductive-age women; however, it is among the most enigmatic of gynecologic disorders. Among the many morbidities associated with endometriosis, foremost is its relationship with pelvic pain. This symptom can affect up to three fourths of all those with clinical evidence of endometriosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Badaway S, Freedman L, Numann P, et al. Diagnosis and management of intestinal endometriosis: a report of five cases. J Reprod Med 1988; 33: 851–55.

    Google Scholar 

  2. Kerr WJ. Endometriosis involving the urinary tract. Clin Obstet Gynecol 1966: 9: 331–57.

    Article  PubMed  Google Scholar 

  3. Horsfield K. Catamenial pleural pain. Eur Respir J 1989; 2: 1013–14.

    PubMed  CAS  Google Scholar 

  4. Vercellini P, Fedele L, Molteni P, et al. Laparoscopy in the diagnosis of gynecologic chronic pelvic pain. Int J Gynaecol Obstet 1990; 32: 261–65.

    Article  PubMed  CAS  Google Scholar 

  5. Chatman D, Zbella E. Pelvic peritoneal defects and endometriosis: further observations. Fertil Steril 1986; 46: 711–14.

    PubMed  CAS  Google Scholar 

  6. Goldstein D, deCholnoky C, Emans S, et al. Laparoscopy in the diagnosis and management of pelvic pain adolescents. J Reprod Med 1980; 24: 251–56.

    PubMed  CAS  Google Scholar 

  7. De Brux J, Bret J, Demay C, Bardiaux M. Recurring pelvic peritonitis. Am J Obstet Gynecol 1968; 102: 501–05.

    PubMed  Google Scholar 

  8. Barbieri R. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 1990; 162: 565–67.

    PubMed  CAS  Google Scholar 

  9. Kresch A, Seifer D, Sachs L, et al. Laparoscopy in 100 women with chronic pelvic pain. Obstet Gynecol 1984; 64: 672–74.

    PubMed  CAS  Google Scholar 

  10. Wheeler J, Malinak L. Epidemiology of endometriosis-associated infertility. J Reprod Med 1989; 34: 41–46.

    PubMed  CAS  Google Scholar 

  11. Boling R, Abbasi R, Ackerman G, et al. Disability from endometriosis in the United States Army. J Reprod Med 1988; 33: 49–52.

    PubMed  CAS  Google Scholar 

  12. Ripps B, Martin D. Focal pelvic tenderness, pelvic pain and dysmenorrhea in endometriosis. J Reprod Med 1991; 36: 470–72.

    PubMed  CAS  Google Scholar 

  13. Liu D, Hitchcock A. Endometriosis: its association with retrograde menstruation, dysmenorrhea and tubal pathology. Br J Obstet Gynaecol 1986; 93: 859–62.

    Article  PubMed  CAS  Google Scholar 

  14. Fedele L, Parazzini F, Bianchi S, et al. Stage and localization of pelvic endometriosis and pain. Fertil Steril 1990; 53: 155–58.

    PubMed  CAS  Google Scholar 

  15. Fedel L, Bianchi S, Bocciolone L, et al. Pain symptoms associated with endometriosis. Obstet Gynecol 1992; 79: 767–69.

    Google Scholar 

  16. Mahmood T, Templeton A, Thomson L, et al. Menstrual symptoms in women with pelvic endometriosis. Br J Obstet Gynaecol 1991; 98: 558–63.

    Article  PubMed  CAS  Google Scholar 

  17. Shaw R. Nafarelin in the treatment of pelvic pain caused by endometriosis. Am J Obstet Gynecol 1990; 162: 574–76.

    PubMed  CAS  Google Scholar 

  18. Buttram VJ. Conservative surgery for endometriosis in the infertile female: a study of 206 patients with implications for both medical and surgical therapy. Fertil Steril 1989; 31: 117–21.

    Google Scholar 

  19. Garcia C, David S. Pelvic endometriosis: infertility and pelvic pain. Am J Obstet Gynecol 1977; 129: 740–47.

    PubMed  CAS  Google Scholar 

  20. Ranney B. Endometriosis: conservative operations. Am J Obstet Gynecol 1980; 107: 743–50.

    Google Scholar 

  21. Williams T, Pratt J. Endometriosis in 1,000 consecutive celiotomies: incidence and management. Am J Obstet Gynecol 1977; 129: 245–50.

    PubMed  CAS  Google Scholar 

  22. Vercellini P, Bocciolone L, Vendola N, et al. Peritoneal endometriosis. Morphologic appearance in women with chronic pelvic pain. J Reprod Med 1991; 36: 533–36.

    CAS  Google Scholar 

  23. Galle P. Clinical presentation and diagnosis of endometriosis. Obstet Gynecol Clin North Am 1989; 16: 29–42.

    PubMed  CAS  Google Scholar 

  24. Fedele L, Marchini M, Acaia B, et al. Dynamics and significance of placebo response in primary dysmenorrhea. Pain 1989; 36: 43–47.

    Article  PubMed  CAS  Google Scholar 

  25. Slocumb J. Operative management of chronic abdominal pelvic pain. Clin Obstet Gynecol 1990; 33: 196–204.

    Article  PubMed  CAS  Google Scholar 

  26. Flandry F, Hunt J, Terry G, et al. Analysis of subjective knee complaints using visual analog scales. Am J Sports Med 1991; 19: 112–18.

    Article  PubMed  CAS  Google Scholar 

  27. Jensen J, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain 1986; 27: 117–26.

    Article  PubMed  CAS  Google Scholar 

  28. Tait R, Pollard C, Margolis R, et al. The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehabil 1987; 68: 438–41.

    PubMed  CAS  Google Scholar 

  29. Wilkie D, Savedra M, Holzerner W, et al. Use of the Mcgill pain questionnaire to measure pain: a meta-analysis. Nurs Res 1990; 36–41.

    Google Scholar 

  30. Koninckx P, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991; 55: 759–65.

    PubMed  CAS  Google Scholar 

  31. Martin D, Hubert G, Vander Zwaag R, et al. Depth of infiltration of endometriosis. JGynecolSurg 1989; 5: 55.

    Google Scholar 

  32. Cornille F, Oosterlynck D, Lauweryns J, et al. Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil Steril 1990; 53: 978–83.

    Google Scholar 

  33. Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1983; 148: 85–90.

    Google Scholar 

  34. Piper P. Pharmacology of leukotriene. Br Med Bull 1983; 39: 255.

    PubMed  CAS  Google Scholar 

  35. Sturgis S, Call B. Endometriosis peritonei. Relation of pain to functional activity. Am J Obstet Gynecol 1954; 68: 1421–31.

    PubMed  CAS  Google Scholar 

  36. Droegemueller W, Herbst A, Mishelle D, et al. Comprehensive gynecology. Mosby, St. Louis, 1987, p 1149.

    Google Scholar 

  37. Nesbitt R,Rizk P. Uterosacral ligament syndrome. Obstet Gynecol 1971; 37: 730–33.

    PubMed  Google Scholar 

  38. Redwine D, Sharp D. Endometriosis of the obturator nerve. Acase report. J Reprod Med 1990; 35: 434–35.

    PubMed  CAS  Google Scholar 

  39. Badaway S, Marshall L, Gaba A, et al. The concentration of 13, 14-dihydro-15-keto-prostaglandin F2alpha and prostaglandin E2 in peritoneal fluid of infertile patients with and without endometriosis. Fertil Steril 1982; 38: 166–70.

    Google Scholar 

  40. Dawood M, Khan-Dawood F, Wilson L. Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am J. Obstet Gynecol 1984; 148: 391–95.

    PubMed  CAS  Google Scholar 

  41. Drake T, O∋Brien W, Ramwell P, et al. Peritoneal fluid thromboxane B2 and 6-keto prostaglandin Fl in endometriosis. Am J Obstet Gynecol 1981; 140: 401–11.

    PubMed  CAS  Google Scholar 

  42. Rapkin A, Bhattacherjee P. Peritoneal fluid eicosanoids in chronic pelvic pain. Prostaglandins 1989; 38: 447–52.

    Article  PubMed  CAS  Google Scholar 

  43. Rock J, Dubin N, Ghodgaonkar R, et al. Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle-days 8 to 12. Fertil Steril 1982; 37: 747–50.

    PubMed  CAS  Google Scholar 

  44. Schenken R, Asch R. Surgical induction of endometriosis in the rabbit: effect on fertility and concentrations of peritoneal fluid prostaglandins. Fertil Steril 1980; 34: 581–87.

    PubMed  CAS  Google Scholar 

  45. Ylikorkala O, Vlinikka L. Prostaglandins and endometriosis. Acta Obstet Gynecol Scand 1983; 113(Suppl): 105–7.

    Article  CAS  Google Scholar 

  46. Ferreira S, Nakamura M, Salete De Abreu Castro M. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 1978; 16: 31–37.

    Article  PubMed  CAS  Google Scholar 

  47. Bray M. The pharmacology and pathophysiology of leukotriene B4. Br Med Bull 1983; 39: 249.

    PubMed  CAS  Google Scholar 

  48. Vernon M. Experimental endometriosis in laboratory animals as a research model. Prog Clin Biol Res 1990; 323: 49–60.

    PubMed  CAS  Google Scholar 

  49. Vernon M, Wilson E. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985; 44: 684–94.

    PubMed  CAS  Google Scholar 

  50. Vernon M, Beard J, Graves K, et al. Classification of endometriotic implants by morphologic appearance of capacity to synthesize prostaglandin F. Fertil Steril 1986; 46.

    Google Scholar 

  51. Harrop-Griffiths J, Katon W, Walker E, et al. The association between chronic pelvic pain, psychiatric diagnoses, and childhood sexual abuse. Obstet Gynecol 1989; 71: 589–94.

    Google Scholar 

  52. Rapkin A, Kames L, Darke L, et al. History of physical and sexual abuse on women with chronic pelvic pain. Obstet Gynecol 1990; 76: 92–96.

    PubMed  CAS  Google Scholar 

  53. Rapkin A, Kames K. The pain management approach to chronic pelvic pain. J Reprod Med 1987; 32: 323–27.

    PubMed  CAS  Google Scholar 

  54. Cooke ID, Thomas EJ. The medical treatment of mild endometriosis. Acta Obstet Gynecol Scand (Suppl) 1989; 150: 27.

    CAS  Google Scholar 

  55. D’Hooghe TM, Bambra CS, Raeymaekers BM, Koninckx PR. Serial laparoscopies over 30 months show that endometriosis in captive baboons (Papio anubis, Papio cynocephalus) is a progressive disease. Fertil Steril 1996; 65: 645–49.

    PubMed  Google Scholar 

  56. Kauppila A, Puolakka J, Ylilorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979; 18: 655.

    Article  PubMed  CAS  Google Scholar 

  57. Floyd WS. Danazol: endocrine and endometrial effects. Int J Fertil 1980; 25: 75.

    PubMed  CAS  Google Scholar 

  58. Goebel R, Rjosk HK. Laboratory and clinical studies with the new antigonadotropin, danazol. Acta Endocrinol 1977; 85: 134.

    Google Scholar 

  59. Barbieri RL, Canich JA, Makis A, et al. Danazol inhibis steroidogenesis. Fertil Steril 1977; 28: 809.

    PubMed  CAS  Google Scholar 

  60. McGinley R, Casey JH. Analysis of progesterone in unextracted serum: a method using danazol — a blocker of steroid binding to proteins. Steroids 1979; 33: 127.

    Article  PubMed  CAS  Google Scholar 

  61. Buttram CV, Jr., Belue JB, Reiter R. Interim report of a study of danazol for the treatment of endometriosis. Fertil Steril 1982; 37: 478.

    PubMed  Google Scholar 

  62. Dmowski WP, Cohen MR. Treatment of endometriosis with an antigonadotropin, danazol: a laparoscopic and histologic evaluation. Obstet Gynecol 1975; 46: 127.

    Google Scholar 

  63. Barbieri RL, Evans S, Kistner RW. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril 1982; 37: 737.

    PubMed  CAS  Google Scholar 

  64. Doberl A, Jeppsson S, Rannevik G. Effect of danazol on serum concentrations of pituitary gonadotropins in post-menopausal women. Acta Obstet Gynecol Scand 1984; 123(Suppl): 95.

    Article  CAS  Google Scholar 

  65. Buttram VC, Jr., Reiter RC, Ward S. Treatment of endometriosis with danazol: report of a six-year prospective study. Fertil Steril 1985; 318: 485.

    Google Scholar 

  66. Henzl RR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl JMed 1988; 318: 485.

    Article  CAS  Google Scholar 

  67. Telimaa S, Puolakka J, Ronnberg L, et al. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987; 1: 13.

    Article  PubMed  CAS  Google Scholar 

  68. Bayer SR, Seibel MM. Medical treatment: danazol. In: Schenkel RS, ed. Endometriosis: contemporary concepts in clinical management. JB Lippincott, Philadelphia, 1989, pp 169–87.

    Google Scholar 

  69. Vercellini P, Trespidi L, Panazza S, et al. Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study. Fertil Steril 1994; 62: 1136–42.

    PubMed  CAS  Google Scholar 

  70. Olive DL. Medical treatment: alternatives to danazol. In: Schenken RS, ed. Endometriosis: contemporary concepts in clinical management. JB Lippincott, Philadelphia, 1989, pp 189–211.

    Google Scholar 

  71. Wheeler JM, Knittle JD, Miller JD, et al. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial II. Assessment of safety. Am J Obstet Gynecol 1993; 169: 26–33.

    PubMed  CAS  Google Scholar 

  72. Rock JA, Truglia JA, Caplan RJ, et al. Zoladex (Goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol 1993; 82: 198–205.

    PubMed  CAS  Google Scholar 

  73. Werlin LB, Hodgen GD. Gonadotropin-releasing hormone against suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen. J Clin Endocrinol Metal 1983; 56: 844.

    Article  CAS  Google Scholar 

  74. Fedele L, Bianchi S, Arcaini L, et al. Buserelin versus danazol in the treatment of endometriosis-associated infertility. Am J Obstet Gynecol 1989; 161: 871.

    PubMed  CAS  Google Scholar 

  75. Lemay A, Maheux R, Faure N, Jean C. Reversible pseudomenopause induced by repetitive luteinizing-hormone-releasing hormone agonist administration (Buserlin): a new approach to the treatment of endometriosis. In: Raynaud J-P, Ojasoo T, Martini L, eds. Medical management of endometriosis. New York, Raven Press, 1984, p 263.

    Google Scholar 

  76. Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993; 59: 511–15.

    PubMed  CAS  Google Scholar 

  77. Hornstein MD, Yuzpe AA, Burry KA, et al. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis-associated pelvic pain. Fertil Steril 1995; 63: 955–62.

    PubMed  CAS  Google Scholar 

  78. Schlaff WD. Personal communications

    Google Scholar 

  79. Surrey E, Fournet N, Voigt B, et al. Effects of sodium etidronate in combination with low-dose norethinodrone in patients administered a long-acting GnRH agonist: a preliminary report. Obstet Gynecol 1993; 81: 581.

    PubMed  CAS  Google Scholar 

  80. Surrey E, Voigt B, Fournet N, et al. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low dose norethindrone “add-back” therapy. Fertil Steril 1995; 63: 747.

    PubMed  CAS  Google Scholar 

  81. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 5th edition, Baltimore, William & Wilkins, 1994; pp 718–23.

    Google Scholar 

  82. Lessey BA, Killam AP, Matzger DA, et al. Immunohistochemical analysis of uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metal 1988; 67: 334.

    Article  CAS  Google Scholar 

  83. Olive DL. Medical treatment: alternative to danazol. In: Schenken RS, ed. Endometriosis: contemporary concepts in clinical management. Philadelphia, JB Lippincott, 1989, pp 189–211.

    Google Scholar 

  84. Hirvonen E, Malkonen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560.

    Article  PubMed  CAS  Google Scholar 

  85. Fahaeus L, Sydsjo A, Wallentin L. Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. Fertil Steril 1986; 45: 503.

    Google Scholar 

  86. Mann DR, Collins DC, Smith MM, et al. Treatment of endometriosis in monkeys: effectiveness of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid. J Clin Endocrinol Metab 1986; 63: 1277.

    Article  PubMed  CAS  Google Scholar 

  87. Andrews MC, Andrews WC, Strauss AF. Effects of progestin-induced pseudopreg-nancy on endometriosis, clinical and microscopic studies. Am J Obstet Gynecol 1959; 78: 776.

    PubMed  CAS  Google Scholar 

  88. Scott RB, Wharton LR, Jr. The effect of estrone and progesterone on the growth of experimental endometriosis in rhesus monkeys. Am J Obstet Gynecol 1957; 74: 852.

    PubMed  CAS  Google Scholar 

  89. Noble AD, Letchworth AT. Medical treatment of endometriosis: a comparative trial. Postgrad Med J 1979 55(Suppl 5): 37.

    PubMed  Google Scholar 

  90. Vercellini P, Trespidi L, Colombo A, et al. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993; 60: 75.

    PubMed  CAS  Google Scholar 

  91. Cornillie FJ, Borsens IA, Vasquez G, et al. Histologie and ultrastructural changes in human endometriotic implants treated with the antiprogesterone steroid ethylnorgestienone (gestrinone) during two months. Int J Gynecol Pathol 1986; 5: 95.

    PubMed  CAS  Google Scholar 

  92. Robyn C, Delogne-Desnoeck J, Bourdoux P, Copinschi G. Endocrine effects of gestrinone. In: Raynaud J-P, O jasoot, Martini L, ed. Medical management of endometriosis. New York, Raven Press, 1984, p 207.

    Google Scholar 

  93. Fedele L, Bianchi S, Viezzoli T, et al. Gesrinone vs. Danazol in the treatment of endometriosis. Fertil Steril 1989; 51: 781.

    PubMed  CAS  Google Scholar 

  94. Worthington M, Irvine LM, Crook D, et al. A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis. Fertil Steril 1993; 59: 522.

    PubMed  CAS  Google Scholar 

  95. Hornstein MD, Gleason RE, Barbieri RL. A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis. Fertil Steril 1990; 53; 237.

    PubMed  CAS  Google Scholar 

  96. Tjaden B, Galetto D, Woodruff JD, et al. Time-related effects of RU486 treatment in experimentally induced endometriosis in the rate. Fertil Steril 1993; 59: 437.

    PubMed  CAS  Google Scholar 

  97. Kettel LM, Murphy AA, Mortola JF, et al. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril 1991; 56: 402.

    PubMed  CAS  Google Scholar 

  98. Kettel LM, Murphy AA, Morale AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996; 65: 23–28.

    PubMed  CAS  Google Scholar 

  99. Karnaky KJ. The use of stilbestrol for endometriosis. South Med J 1948; 41: 1109.

    Article  PubMed  CAS  Google Scholar 

  100. Katayama KP, Manuel M, Jones HW Jr, et al. Methyltestosterone treatment of infertility associated with pelvic endometriosis. Fertil Steril 1976; 2783.

    Google Scholar 

  101. Haber GM, Behelak YF. Preliminary report on the use of tamoxifen in the treatment of endometriosis. Am J Obstet Gynecol 1987; 156: 582.

    PubMed  CAS  Google Scholar 

  102. Koninckx PR, Muyldermans M, Brosens IA. Unexplained infertility: “Leuven” considerations. Eur J Obstet Gynecol Reprod Biol 1984; 18: 403.

    Article  PubMed  CAS  Google Scholar 

  103. Steinleitner A, Lambert H, Suarex M, et al. Immunomodulation in the treatment of endometriosis-associated subfertility: use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis in a rodent model. Fertil Steril 1991; 56: 975–79.

    PubMed  CAS  Google Scholar 

  104. Nezhat CR, Nezhat FR, Metzger DA, et al. Adhesion reformation after reproductive surgery by videolaserscopy. Fertil Steril 1990; 53: 1008.

    PubMed  CAS  Google Scholar 

  105. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence and management. Am J Obstet Gynecol 1977; 129: 245.

    Google Scholar 

  106. Gordgts S, Boeckx W, Brosens I. Microsurgery of endometriosis in infertile patients. Fertil Steril 1984; 42: 520.

    Google Scholar 

  107. Adhesion Study Group. Reduction in postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertil Steril 1983; 40: 612.

    Google Scholar 

  108. Redwine DB. Treatment of endometriosis-associated pain. Inf Reprod Med Clin North Am 1992; 3: 697.

    Google Scholar 

  109. Nezhat C, Hood J, Winer W, et al. Videolaseroscopy and laser laparoscopy in gynecology. Br J Hosp Med 1987; 38: 219–24.

    PubMed  CAS  Google Scholar 

  110. Sutton CJ, Ewen SP, Whitelaw N, et al. Prospective, randomized, double-blind controlled trial of laser laparoscopy in the treatment of pelvic pain associated minimal, mild, and moderate endometriosis. Fertil Steril 1994; 62: 696–700.

    PubMed  CAS  Google Scholar 

  111. Walters MD. Definitive surgery. In: Schenken RS, ed. Endometriosis: contemporary concepts in clinical management. Philadelphia, JB Lippincott, 1989, pp 267–78.

    Google Scholar 

  112. Ranney B. Endometriosis. III. Complete operations. Reasons, sequelae, treatment. Am J Obstet Gynecol, 1971; 109: 1137.

    PubMed  CAS  Google Scholar 

  113. Kaupilla A, Puolakka J, Ykikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979; 18: 655.

    Article  Google Scholar 

  114. Kaupilla A, Ronnberg L, Naproxen sodium in dysmenorrhea secondary to endometriosis. Obstet Gynecol 1985; 65: 379.

    Google Scholar 

  115. Lichten EM, Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reprod Med 1987; 32: 37–41.

    PubMed  CAS  Google Scholar 

  116. Tjaden B, Schlaff WD, Kimball A, et al. The efficacy of presacral neurectomy for the relief of midline dysmenorrhea. Obstet Gynecol 1990; 76: 89.

    PubMed  CAS  Google Scholar 

  117. Candiani GB, Fedele L, Vercellini P, et al. Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study. Am J Obstet Gynecol 1992; 167: 100–103.

    PubMed  CAS  Google Scholar 

  118. Edmonds DK. Add-back therapy in the treatment of endometriosis: the European experience. Br J Obstet Gynaecol 1996; 103 Suppl 14: 10–13.

    PubMed  CAS  Google Scholar 

  119. Cedars M, Lu J, Meldrum D, Judd H. Treatment of endometriosis with a long acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 1990; 75: 641.

    PubMed  CAS  Google Scholar 

  120. Surrey E, Gambone J, Lu J, Judd H. The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Fertil Steril 1990; 53: 620.

    PubMed  CAS  Google Scholar 

  121. Riis B, Christiensen C, Johnsen J, Jacobsen J. It is possible to prevent bone loss in young women treated with luteinizing-hormone releasing-hormone agonists? J Clin Endocrinol Metab 1990; 70: 920.

    Article  PubMed  CAS  Google Scholar 

  122. Surrey E, Judd H. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab 1992; 75: 558.

    Article  PubMed  CAS  Google Scholar 

  123. Friedman AJ, Hornstein MD. Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain. Fertil Steril 1993; 60: 236–41.

    PubMed  CAS  Google Scholar 

  124. Surrey ES, Voigt B, Fournet N, Judd HL. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy. Fertil Steril 1995; 63: 747–55.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. David L. Olive
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard E. Blackwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan B. Copperman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Division of Reproductive Biology, and Endocrinology, University of Alabama Medical School, Birmingham, AL, 35233-7333, USA

    Richard E. Blackwell PhD, MD

  2. Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT, 06510, USA

    David L. Olive MD

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Olive, D.L., Blackwell, R.E., Copperman, A.B. (1998). Endometriosis and Pelvic Pain. In: Blackwell, R.E., Olive, D.L. (eds) Chronic Pelvic Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1752-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1752-7_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7265-6

  • Online ISBN: 978-1-4612-1752-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation